Início › Mielofibrose › Massachusetts › Boston
Ensaios clínicos de Mielofibrose em Boston, MA
12 estudos para Mielofibrose estão buscando participantes em locais em Boston e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RecrutandoFase 1/2
- Massachusetts General Hospital, Boston
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RecrutandoFase 3
- Tufts Medical Center, Boston
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
RecrutandoFase 1
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
RecrutandoFase 1/2
- Massachusetts General Hospital (Data Collection Only), Boston
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RecrutandoFase 1Voluntários saudáveis bem-vindos
- Brigham and Women's Hospital, Boston
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecrutandoFase 1
- Massachusetts General Hospital, Boston
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RecrutandoFase 1
- Dana Farber Cancer Institute, Boston
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RecrutandoFase 1
- Dana Farber Cancer Institute, Boston
Momelotinib During and After HCT in Myelofibrosis
RecrutandoFase 1
- Massachusetts General Hospital, Boston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RecrutandoFase 2
- Dana-Farber Cancer Institute, Boston
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
RecrutandoFase 2Voluntários saudáveis bem-vindos
- DFCI/BWH Brigham and Women's Hospital, Boston
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
RecrutandoFase 3
- Dana Farber Cancer Institute, Boston
Ensaios de Mielofibrose em outras cidades
- Houston, TX19 estudos
- New York City, NY18 estudos
- Durham, NC12 estudos
- Columbus, OH11 estudos
- Seattle, WA11 estudos
- Salt Lake City, UT10 estudos
- Miami, FL10 estudos
- Nashville, TN9 estudos
- Cleveland, OH9 estudos
- Tampa, FL9 estudos
- Atlanta, GA9 estudos
- Baldwin Park, CA9 estudos
Outros estudos em Boston
- Câncer de Mama111 estudos
- Câncer de Pulmão de Não Pequenas Células90 estudos
- Câncer (todos os tipos)86 estudos
- Câncer Colorretal63 estudos
- Câncer Metastático63 estudos
- Câncer de Pulmão62 estudos
- Câncer de Ovário61 estudos
- Câncer de Próstata59 estudos
- Depressão52 estudos
- Câncer Endometrial50 estudos
- Insuficiência Cardíaca44 estudos
- Leucemia Mieloide Aguda44 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.